Avalere Senior Vice President Is a Formal Member of USP NLEC Panel
Summary
Avalere senior vice president, Gillian Woollett, has been appointed to the U.S. Pharmacopeial Convention’s Nomenclature and Labeling Expert Committee (NLEC).
Please note: This is an archived post. Some of the information and data discussed in this article may be out of date. It is preserved here for historical reference but should not be used as the basis for business decisions. Please see our main Insights section for more recent posts.
The NLEC is a core component in USP’s governance and is responsible for developing and revising USP standards that comprise its compendia:
- USP and National Formulary
- USP Compounding Compendium
- Herbal Medicines Compendium
- Dietary Supplements Compendium
- Food Chemicals Codex
Gillian will serve on the NLEC for a 5-year term.
“Gillian brings with her a deep understanding of the FDA and life sciences sectors that will support her in this significant scientific function,” said Dan Mendelson, CEO of Avalere.
Gillian is a well-known expert on scientific and regulatory strategy and policy. Prior to joining Avalere, she was chief scientist at Engel & Novitt, LLP, and was vice president, Science and Regulatory Affairs at the Biotechnology Industry Organization (BIO). She joined BIO after being associate vice president at the Pharmaceutical Research and Manufacturers of America. She has been an appointee on federal advisory committees to the Centers for Disease Control and Prevention and the Department of Commerce. Trained as a molecular biologist/immunologist, Gillian publishes in peer-reviewed literature on biotechnology topics and is a frequent speaker on emerging biosciences and their ability to support better and more focused therapies. Gillian has a BA, an MA in the natural sciences tripos (biochemistry) from the University of Cambridge, and a DPhil in immunology from the University of Oxford.
Related Content
